Linking lncRNAs to regulation, pathogenesis, and diagnosis of pulmonary hypertension

References

• Kushimo OA, Mbakwem AC, Ajuluchukwu JN. Clinical and echocardiographic correlates of pulmonary hypertension among heart failure patients in Lagos, south-western Nigeria. Cardiovasc J Afr. 2019;30(1):9–14.
   PubMed Web of Science ®Google Scholar
• Gual-Capllonch F, Teis A, Ferrer E. Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation. Echocardiography. 2018;35(11):1736–1745.
   PubMed Web of Science ®Google Scholar
• Schermuly RT, Ghofrani HA, Wilkins MR, et al. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8(8):443–455.
   PubMed Web of Science ®Google Scholar
• Mallory GB, Jr. Pulmonary hypertension in early life. Lancet. 2012;379(9815):500–501.
   PubMed Web of Science ®Google Scholar
• Khirfan G, Tonelli AR, Ramsey J, et al. Palliative care in pulmonary arterial hypertension: an underutilised treatment. Eur Respir Rev. 2018;27(150):180069.
   PubMed Web of Science ®Google Scholar
• Strange G, Playford D, Stewart S, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart. 2012;98(24):1805–1811.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D34–D41.
   PubMed Web of Science ®Google Scholar
• Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132(2):373–379.
   PubMed Web of Science ®Google Scholar
• Frost AE, Badesch DB, Barst RJ, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries. Chest. 2011;139(1):128–137.
   PubMed Web of Science ®Google Scholar
• Klinger JR, Elliott CG, Levine DJ, et al. Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 2019;155(3):565–586.
   PubMed Web of Science ®Google Scholar
• Lan NSH, Massam BD, Kulkarni SS, et al. Pulmonary arterial hypertension: pathophysiology and treatment. Diseases. 2018;6(2):38.
   Google Scholar
• Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics. 2017;15(3):177–186.
   PubMed Web of Science ®Google Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346.
   PubMed Web of Science ®Google Scholar
• Joh RI, Palmieri CM, Hill IT, et al. Regulation of histone methylation by noncoding RNAs. Biochim Biophys Acta. 2014;1839(12):1385–1394.
   PubMed Web of Science ®Google Scholar
• Bell RD, Long X, Lin M, et al. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol. 2014;34(6):1249–1259.
   PubMed Web of Science ®Google Scholar
• Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15(6):423–437.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Wang DZ. Non-coding RNAs including miRNAs and lncRNAs in cardiovascular biology and disease. Cells. 2014;3(3):883–898.
   PubMedGoogle Scholar
• Humbert M, Montani D, Evgenov OV, et al. Definition and classification of pulmonary hypertension. Handb Exp Pharmacol. 2013;218:3–29.
   PubMedGoogle Scholar
• Olschewski A, Berghausen EM, Eichstaedt CA, et al. Pathobiology, pathology and genetics of pulmonary hypertension: update from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:4–10.
   PubMedGoogle Scholar
• Yu Q, Chan SY. Mitochondrial and metabolic drivers of pulmonary vascular endothelial dysfunction in pulmonary hypertension. Adv Exp Med Biol. 2017;967:373–383.
   PubMedGoogle Scholar
• Wang Y, Dai S, Cheng X, et al. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension. Nutr Metab Cardiovasc Dis. 2019;29(6):639–651.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Shen W, Zhu H, et al. Zoledronate inhibits fibroblasts' proliferation and activation via targeting TGF-beta signaling pathway. Drug Des Dev Ther. 2018;12:3021–3031.
   PubMed Web of Science ®Google Scholar
• Oliveira SDS, Castellon M, Chen J, et al. Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-beta-driven pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 2017;312(5):L760–L771.
   PubMed Web of Science ®Google Scholar
• Vaillancourt M, Ruffenach G, Meloche J, et al. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Can J Cardiol. 2015;31(4):407–415.
   PubMed Web of Science ®Google Scholar
• Tuder RM, Archer SL, Dorfmuller P, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25):D4–D12.
   PubMed Web of Science ®Google Scholar
• Karlsson O, Baccarelli AA. Environmental health and long non-coding RNAs. Curr Envir Health Rep. 2016;3(3):178–187.
   PubMedGoogle Scholar
• Bunch H. Gene regulation of mammalian long non-coding RNA. Mol Genet Genomics 2018;293(1):1–15.
   PubMed Web of Science ®Google Scholar
• Shi Z, Pan B, Feng S. The emerging role of long non-coding RNA in spinal cord injury. J Cell Mol Med. 2018;22(4):2055–2061.
   PubMed Web of Science ®Google Scholar
• O'Leary VB, Hain S, Maugg D, et al. Long non-coding RNA PARTICLE bridges histone and DNA methylation. Sci Rep. 2017;7:1790.
   PubMed Web of Science ®Google Scholar
• Yan H, Liang H, Liu L, et al. Long noncoding RNA NEAT1 sponges miR‑125a‑5p to suppress cardiomyocyte apoptosis via BCL2L12. Mol Med Rep. 2019;19(5):4468–4474.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao Y, Jiang X, et al. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J Exp Clin Cancer Res. 2018;37(1):81.
   PubMedGoogle Scholar
• Liu Y, Zhang R, Ying K. Long noncoding RNAs: novel links in respiratory diseases (review). Mol Med Rep. 2015;11(6):4025–4031.
   PubMed Web of Science ®Google Scholar
• Ono H, Motoi N, Nagano H, et al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014;3(3):632–642.
   PubMed Web of Science ®Google Scholar
• Tang W, Shen Z, Guo J, et al. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-beta induction in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2951–2964.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Xu Q, et al. Long non-coding RNA-ATB promotes EMT during silica-induced pulmonary fibrosis by competitively binding miR-200c. Biochim Biophys Acta Mol Basis Dis. 2018;1864(2):420–431.
   PubMed Web of Science ®Google Scholar
• Kim D, George MP. Pulmonary Hypertension. Med Clin North Am. 2019;103(3):413–423.
   PubMed Web of Science ®Google Scholar
• Wang X, Yan C, Xu X, et al. Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model. Gene. 2016;579(1):23–28.
   PubMed Web of Science ®Google Scholar
• Brock M, Schuoler C, Leuenberger C, et al. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation. Exp Biol Med. 2017;242(5):487–496.
   Web of Science ®Google Scholar
• Zhang H, Liu Y, Yan L, et al. Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation. Cardiovasc Res. 2019;115(3):647–657.
   PubMed Web of Science ®Google Scholar
• Zhu TT, Sun RL, Yin YL, et al. Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells. Pflugers Arch. 2019;471(2):347–355.
   PubMed Web of Science ®Google Scholar
• Sun Z, Nie X, Sun S, et al. Long non-coding RNA MEG3 downregulation triggers human pulmonary artery smooth muscle cell proliferation and migration via the p53 signaling pathway. Cell Physiol Biochem. 2017;42(6):2569–2581.
   PubMedGoogle Scholar
• Zhu B, Gong Y, Yan G, et al. Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21. Biochem Biophys Res Commun. 2018;495(3):2125–2132.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun Z, Zhu J, et al. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. J Cell Physiol. 2018;233(6):4801–4814.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Z, Wang Y, et al. Overexpressed long noncoding RNA CPS1-IT alleviates pulmonary arterial hypertension in obstructive sleep apnea by reducing interleukin-1beta expression via HIF1 transcriptional activity. J Cell Physiol. 2019;234(11):19715–19727.
   PubMed Web of Science ®Google Scholar
• Schlosser K, Hanson J, Villeneuve PJ, et al. Assessment of circulating LncRNAs under physiologic and pathologic conditions in humans reveals potential limitations as biomarkers. Sci Rep. 2016;6(1):36596.
   PubMedGoogle Scholar
• Han B, Bu P, Meng X, et al. Microarray profiling of long non-coding RNAs associated with idiopathic pulmonary arterial hypertension. Exp Ther Med. 2017;13(6):2657–2666.
   PubMed Web of Science ®Google Scholar
• Jandl K, Thekkekara Puthenparampil H, Marsh LM, et al. Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1. J Pathol. 2019;247(3):357–370.
   PubMed Web of Science ®Google Scholar
• Gu S, Li G, Zhang X, et al. Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension. Mol Med Rep. 2015;11(4):2631–2643.
   PubMed Web of Science ®Google Scholar
• Josipovic I, Fork C, Preussner J, et al. PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells. Acta Physiol. 2016;218:13–27.
   PubMed Web of Science ®Google Scholar
• Szafranski P, Dharmadhikari AV, Brosens E, et al. Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder. Genome Res. 2013;23(1):23–33.
   PubMed Web of Science ®Google Scholar
• Szafranski P, Dharmadhikari AV, Wambach JA, et al. Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet. 2014;164A:2013–2019.
   PubMedGoogle Scholar
• Szafranski P, Gambin T, Dharmadhikari AV, et al. Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. Hum Genet. 2016;135(5):569–586.
   PubMed Web of Science ®Google Scholar
• Szafranski P, Herrera C, Proe LA, et al. Narrowing the FOXF1 distant enhancer region on 16q24.1 critical for ACDMPV. Clin Epigenet. 2016;8(1):112.
   PubMedGoogle Scholar
• Chen J, Guo J, Cui X, et al. The long noncoding RNA LnRPT is regulated by PDGF-BB and modulates the proliferation of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 2018;58(2):181–193.
   PubMed Web of Science ®Google Scholar
• Gong J, Chen Z, Chen Y, et al. Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension. Respir Res. 2019;20(1):53.
   PubMedGoogle Scholar
• Leung A, Trac C, Jin W, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res. 2013;113(3):266–278.
   PubMed Web of Science ®Google Scholar
• Su H, Xu X, Yan C, et al. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT1R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res. 2018;19(1):254.
   PubMed Web of Science ®Google Scholar
• Sun Z, Liu Y, Yu F, et al. Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline. Biomed Pharmacother. 2019;115:108933.
   PubMed Web of Science ®Google Scholar
• Leisegang MS, Fork C, Josipovic I, et al. Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation. 2017;136(1):65–79.
   PubMed Web of Science ®Google Scholar
• Michalik KM, You X, Manavski Y, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389–1397.
   PubMed Web of Science ®Google Scholar
• Li K, Blum Y, Verma A, et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood. 2010;115(1):133–139.
   PubMed Web of Science ®Google Scholar
• Bischoff FC, Werner A, John D, et al. Identification and functional characterization of hypoxia-induced endoplasmic reticulum stress regulating lncRNA (HypERlnc) in pericytes. Circ Res. 2017;121(4):368–375.
   PubMed Web of Science ®Google Scholar
• Ono K, Kuwabara Y, Horie T, et al. Long non-coding RNAs as key regulators of cardiovascular diseases. Circ J. 2018;82(5):1231–1236.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Du W, Yang B. Long non-coding RNAs as new regulators of cardiac electrophysiology and arrhythmias: molecular mechanisms, therapeutic implications and challenges. Pharmacol Ther. 2019;2:107389.
   Google Scholar
• Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351(16):1655–1665.
   PubMed Web of Science ®Google Scholar
• Nagaoka M, Goda A, Takeuchi K, et al. Nocturnal hypoxemia, but not sleep apnea, is associated with a poor prognosis in patients with pulmonary arterial hypertension. Circ J. 2018;82(12):3076–3081.
   PubMed Web of Science ®Google Scholar
• Hua C, Zhao J, Wang H, et al. Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: in vivo and in vitro studies. Biomed Pharmacother. 2018;107:937–944.
   PubMed Web of Science ®Google Scholar
• Yamanaka R, Otsuka F, Nakamura K, et al. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Hypertens Res. 2010;33(5):435–445.
   PubMed Web of Science ®Google Scholar
• Jones PL, Cowan KN, Rabinovitch M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol. 1997;150(4):1349–1360.
   PubMed Web of Science ®Google Scholar
• Pak O, Aldashev A, Welsh D, et al. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J. 2007;30(2):364–372.
   PubMed Web of Science ®Google Scholar
• Zhao M, Barber T, Cistulli PA, et al. Simulation of upper airway occlusion without and with mandibular advancement in obstructive sleep apnea using fluid-structure interaction. J Biomech. 2013;46(15):2586–2592.
   PubMed Web of Science ®Google Scholar
• Karamanzanis G, Panou F, Lazaros G, et al. Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study. Sleep Breath 2015;19(1):343–350.
   PubMed Web of Science ®Google Scholar
• Sharma S, Fox H, Aguilar F, et al. Auto positive airway pressure therapy reduces pulmonary pressures in adults admitted for acute heart failure with pulmonary hypertension and obstructive sleep apnea. The ASAP-HF Pilot Trial. Sleep. 2019;42:zsz100.
   PubMedGoogle Scholar
• Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
   PubMed Web of Science ®Google Scholar
• McGoon MD, Benza RL, Escribano-Subias P, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013;62(25):D51–D59.
   PubMed Web of Science ®Google Scholar
• Newman JH, Wheeler L, Lane KB, et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med. 2001;345(5):319–324.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Marsh LM, Pieper M, et al. Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients. Am J Physiol Lung Cell Mol Physiol. 2015;308(10):L1002–L1013.
   PubMed Web of Science ®Google Scholar
• Edward JA, Mandras S. An update on the management of chronic thromboembolic pulmonary hypertension. Curr Probl Cardiol. 2017;42(1):7–38.
   PubMed Web of Science ®Google Scholar
• Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462–468.
   PubMed Web of Science ®Google Scholar
• Zia A, Russell J, Sarode R, et al. Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2017;160:1–8.
   PubMed Web of Science ®Google Scholar
• Robbins IM, Pugh ME, Hemnes AR. Update on chronic thromboembolic pulmonary hypertension. Trends Cardiovasc Med. 2017;27(1):29–37.
   PubMed Web of Science ®Google Scholar
• Michalsky MP, Arca MJ, Groenman F, et al. Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg. 2005;40(7):1100–1105.
   PubMed Web of Science ®Google Scholar
• Slot E, Edel G, Cutz E, et al. Alveolar capillary dysplasia with misalignment of the pulmonary veins: clinical, histological, and genetic aspects. Pulm Circ. 2018;8(3):204589401879514. 2045894018795143.
   Web of Science ®Google Scholar
• deMello DE. Pulmonary pathology. Semin Neonatol. 2004;9(4):311–329.
   PubMedGoogle Scholar
• Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar capillary dysplasia. Am J Respir Crit Care Med. 2011;184(2):172–179.
   PubMed Web of Science ®Google Scholar
• Stankiewicz P, Sen P, Bhatt SS, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet. 2009;84(6):780–791.
   PubMed Web of Science ®Google Scholar
• Liang S, Yu H, Chen X, et al. PDGF-BB/KLF4/VEGF signaling axis in pulmonary artery endothelial cell angiogenesis. Cell Physiol Biochem. 2017;41(6):2333–2349.
   PubMedGoogle Scholar
• Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018;114(4):622–634.
   PubMed Web of Science ®Google Scholar
• Sztuka K, Jasińska-Stroschein M. Animal models of pulmonary arterial hypertension: a systematic review and meta-analysis of data from 6126 animals. Pharmacol Res. 2017;125:201–214.
   PubMed Web of Science ®Google Scholar
• Pei Z, Du X, Song Y, et al. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/beta-catenin signaling pathway. Oncotarget 2017;8(11):18145–18153.
   PubMedGoogle Scholar
• Jie W, Guo J, Shen Z, et al. Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells. Exp Mol Pathol. 2010;89(3):301–306.
   PubMed Web of Science ®Google Scholar
• Xu D, Gu JT, Yi B, et al. Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum. J Cell Mol Med. 2015;19(10):2453–2461.
   PubMed Web of Science ®Google Scholar
• Wang C, Gao Y, Zhu L, et al. Treatment patterns in patients with newly diagnosed type 2 diabetes in China: a retrospective, longitudinal database study. Clin Ther. 2019;41(8):1440–1452.
   PubMed Web of Science ®Google Scholar
• Omura J, Satoh K, Kikuchi N, et al. Protective roles of endothelial AMP-activated protein kinase against hypoxia-induced pulmonary hypertension in mice. Circ Res. 2016;119(2):197–209.
   PubMed Web of Science ®Google Scholar
• Dean A, Nilsen M, Loughlin L, et al. Metformin reverses development of pulmonary hypertension via aromatase inhibition. Hypertension 2016;68(2):446–454.
   PubMed Web of Science ®Google Scholar
• Townsley MI. Structure and composition of pulmonary arteries, capillaries, and veins. Compr Physiol. 2012;2(1):675–709.
   PubMed Web of Science ®Google Scholar
• Maier JA. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci. 2012;122(9):397–407.
   PubMed Web of Science ®Google Scholar
• Zhu X, Xie M, Wang K, et al. The effect of puerarin against IL-1beta-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2). Mol Vis. 2014;20:1815–1823.
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Eklund L, Kangas J, Saharinen P. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems. Clin Sci. 2017;131(1):87–103.
   PubMed Web of Science ®Google Scholar
• Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376(6535):70–74.
   PubMed Web of Science ®Google Scholar
• Halaidych OV, Mummery CL, Orlova VV. Quantifying Ca(2+) signaling and contraction in vascular pericytes and smooth muscle cells. Biochem Biophys Res Commun. 2019;513(1):112–118.
   PubMed Web of Science ®Google Scholar
• Jones R. Ultrastructural analysis of contractile cell development in lung microvessels in hyperoxic pulmonary hypertension. Fibroblasts and intermediate cells selectively reorganize nonmuscular segments. Am J Pathol. 1992;141(6):1491–1505.
   PubMed Web of Science ®Google Scholar
• Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology. Arterioscler Thromb Vasc Biol. 2011;31(11):2391–2396.
   PubMed Web of Science ®Google Scholar
• Micheletti R, Plaisance I, Abraham BJ, et al. The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Sci Transl Med. 2017;9:eaai9118.
   PubMed Web of Science ®Google Scholar
• Deng L, Bradshaw AC, Baker AH. Role of noncoding RNA in vascular remodelling. Curr Opin Lipidol. 2016;27(5):439–448.
   PubMed Web of Science ®Google Scholar
• Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494–501.
   PubMed Web of Science ®Google Scholar
• Morrell NW, Adnot S, Archer SL, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1):S20–S31.
   PubMed Web of Science ®Google Scholar
• Qi L, Lv T, Cheng Y, et al. Fasudil dichloroacetate (FDCA), an orally available agent with potent therapeutic efficiency on monocrotaline-induced pulmonary arterial hypertension rats. Bioorg Med Chem Lett. 2019;29(14):1812–1818.
   PubMed Web of Science ®Google Scholar
• Dunlap B, Weyer G. Pulmonary hypertension: diagnosis and treatment. Am Fam Physician. 2016;94(6):463–469.
   PubMed Web of Science ®Google Scholar